Snapshot · Russell 3000 · generated 2026-11-11 21:49 UTC

RPRX — Royalty Pharma plc

UNDERVALUED (MOS +46.8%) · Quality 46/100

Value Score 30 days ago: 38.3 → today 26.7

RPRX - Royalty Pharma plc
Data generated 2026-11-11 21:49 UTC (nightly scan, universe: Russell 3000).
Price: 70.01 USD
Intrinsic value: 131.57 USD
Margin of safety: +46.8%
Implied growth (reverse DCF): -3.8% (model assumes +5.2%)
Valuation: UNDERVALUED
Value Score: 26.7
Quality: 46/100
Moat score: 42 (erosion: none)
UNDERVALUED (MOS +46.8%) - Quality 46/100
Source: StocksDeepDive - https://stocksdeepdive.com/s/RPRX
Factual information and general commentary only. StocksDeepDive publishes data, model outputs and described calculations from stated inputs. Nothing on this site takes your personal objectives, financial situation or needs into account, and nothing here is financial product advice or a recommendation to buy, hold or sell any security. Model outputs depend entirely on their stated inputs and assumptions. Consider seeking advice from a licensed adviser before acting. Data via Yahoo Finance, Google Trends, StockTwits and NewsAPI; figures may be delayed or revised.

Price

70.01

Intrinsic value

131.57

Margin of safety

+46.8%

Implied growth (reverse DCF)

-3.8%

model assumes +5.2%

Value Score

26.7

Quality

Psychology

-32.1

Discovery

14.9

price/volume attention only

Moat score

erosion: none

Value Score: bottom 44% of Russell 3000 · Quality: bottom 12%

Dividend: 0.925/share (TTM) · yield 1.3% · payout 49%

Open the interactive Deep Dive for RPRX →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/RPRX - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is RPRX undervalued?

As of 2026-11-11, RPRX trades at 70.01 against a computed intrinsic value of 131.57 (+46.8% margin of safety) - StocksDeepDive's valuation label for this is UNDERVALUED. This is a described calculation from public data, not a recommendation.

What is Royalty Pharma plc's Value Score?

Royalty Pharma plc's Value Score is 26.7 as of 2026-11-11 - it combines value, quality, crowd psychology and market attention into one number.

Does RPRX pay a dividend?

Yes - RPRX's trailing twelve-month dividend is 0.925/share, a yield of 1.3% at the current price (as of 2026-11-11).